Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W N Burnette

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
The New Biologist|April 1, 1992
Vaccine development: necessity as the mother of inventionW N Burnette
Analytical Biochemistry|April 1, 1981
"Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein AW N Burnette
Behring Institute Mitteilungen|February 1, 1997
Bacterial ADP-ribosylating toxins: form, function, and recombinant vaccine developmentW N Burnette
Advances in Experimental Medicine and Biology|January 1, 1996
Parameters for the rational design of genetic toxoid vaccinesW N Burnette
Structure (London, England : 1993)|March 15, 1994
AB5 ADP-ribosylating toxins: comparative anatomy and physiologyW N Burnette
Current Opinion in Biotechnology|December 1, 1991
Recombinant subunit vaccinesW N Burnette
Bio/Technology (Nature Publishing Company)|November 1, 1990
The advent of recombinant pertussis vaccinesW N Burnette
Journal of Virology|May 1, 1978
Interstrain variation of the major internal structural component (p30gag) of two murine oncornaviruses: comparative immunochemical, biochemical, and biophysical analysisW N Burnette, W M Mitchell
Advances in Experimental Medicine and Biology|January 1, 1995
Molecular engineering of cholera toxinW N Burnette, H R Kaslow, J Moss
Journal of Virology|April 1, 1978
Stoichiometry and specificity of binding of Rauscher oncovirus 10,000-dalton (p10) structural protein to nucleic acidsM Schulein, W N Burnette, J T August
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
The New Biologist|April 1, 1992
Vaccine development: necessity as the mother of inventionW N Burnette
Analytical Biochemistry|April 1, 1981
"Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein AW N Burnette
Behring Institute Mitteilungen|February 1, 1997
Bacterial ADP-ribosylating toxins: form, function, and recombinant vaccine developmentW N Burnette
Advances in Experimental Medicine and Biology|January 1, 1996
Parameters for the rational design of genetic toxoid vaccinesW N Burnette
Structure (London, England : 1993)|March 15, 1994
AB5 ADP-ribosylating toxins: comparative anatomy and physiologyW N Burnette
Current Opinion in Biotechnology|December 1, 1991
Recombinant subunit vaccinesW N Burnette
Bio/Technology (Nature Publishing Company)|November 1, 1990
The advent of recombinant pertussis vaccinesW N Burnette
Journal of Virology|May 1, 1978
Interstrain variation of the major internal structural component (p30gag) of two murine oncornaviruses: comparative immunochemical, biochemical, and biophysical analysisW N Burnette, W M Mitchell
Advances in Experimental Medicine and Biology|January 1, 1995
Molecular engineering of cholera toxinW N Burnette, H R Kaslow, J Moss
Journal of Virology|April 1, 1978
Stoichiometry and specificity of binding of Rauscher oncovirus 10,000-dalton (p10) structural protein to nucleic acidsM Schulein, W N Burnette, J T August
Pageof 4